» Articles » PMID: 6573527

Cutaneous Melanoma in Relation to Exogenous Hormones and Reproductive Factors

Overview
Specialty Oncology
Date 1983 May 1
PMID 6573527
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Eighty-seven women of ages 37-74, who resided in King County, Wash., and who had been diagnosed between July 1976 and November 1979 as having cutaneous malignant melanoma, were interviewed regarding prior use of estrogen-containing preparations and reproductive history. The responses were compared with those of a random sample of 863 women from the same county. Among the 61 women with superficial spreading melanoma (SSM), use of oral contraceptives for 5 years or more was more common than among controls. The estimated relative risks for users of 5-9 and 10 years or more were 2.4 and 3.6, respectively. No differences between cases and controls were noted for oral contraceptive use of 4 years or less. Giving birth to a first child after age 30 was also associated with an increased relative risk of SSM. Although the positive findings regarding oral contraceptive use and age at birth of first child must be interpreted cautiously pending results of other studies, they suggest that hormonal factors can play a role in the etiology of SSM.

Citing Articles

Exogenous Hormone Factors in Relation to the Risk of Malignant Melanoma in Women: A Systematic Review and Meta-Analysis.

Chiavarini M, Naldini G, Giacchetta I, Fabiani R Cancers (Basel). 2022; 14(13).

PMID: 35804961 PMC: 9264834. DOI: 10.3390/cancers14133192.


Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis.

Sun Q, Sun H, Cong L, Zheng Y, Wu N, Cong X Clin Epidemiol. 2020; 12:1183-1203.

PMID: 33149695 PMC: 7605627. DOI: 10.2147/CLEP.S273566.


Age at first birth and melanoma risk: a meta-analysis.

Li Z, Gu M, Cen Y Int J Clin Exp Med. 2015; 7(12):5201-9.

PMID: 25664022 PMC: 4307469.


Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.

Tang J, Spaunhurst K, Chlebowski R, Wactawski-Wende J, Keiser E, Thomas F J Natl Cancer Inst. 2011; 103(19):1469-75.

PMID: 21878677 PMC: 3186783. DOI: 10.1093/jnci/djr333.


Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.

Firoz E, Warycha M, Zakrzewski J, Pollens D, Wang G, Shapiro R Clin Cancer Res. 2009; 15(7):2573-80.

PMID: 19318491 PMC: 3881546. DOI: 10.1158/1078-0432.CCR-08-2678.